Lindis Blood Care

Lindis Blood Care is developing a medical device to be used in oncology for the operation of tumours in order to open up the possibility of self-blood administration of blood collected during the operation. The product consists of a combination of an antibody and filter and serves to remove cancer cells from the blood.


Over 5 Million Euros For Lindis Blood Care: Development Of A New Product For The Removal Of Tumor Cells From Surgical Blood

Clinical development of the product CATUVAB secured CATUVAB is designed to enable tumor cell free return of autologous blood collected during a surgery without significantly altering standard surgical procedures High-Tech Gründerfonds (HTGF), Brandenburg Kapital and five private investors participated in a capital…


Neuendorfstraße 20B
16761 Hennigsdorf

In portfolio

23. Sep 2019